SynteractHCR Promotes Education to Take Time and Cost out of Drug Development with ICD+ Webinar Series

SynteractHCR Promotes Education to Take Time and Cost out of Drug Development
                           with ICD+ Webinar Series

- Industry experts will provide insights in series of webinars to identify
efficiencies for clinical trials-

PR Newswire

SAN DIEGO, Sept. 11, 2013

SAN DIEGO, Sept. 11, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global
contract research organization (CRO), will host an educational series on
"Taking Time and Cost Out of Drug Development," with three Webinars to support
its Intelligent Clinical Development (ICD+) platform. Each webinar will be
presented by a SynteractHCR expert with biopharma industry panelists and will
be free of charge to attendees.


The first webinar, "Selecting the Right Electronic Data Capture (EDC)
Platform" will be held on Monday, Sept. 23 from 1 to 2 p.m. EDT. It will
include a 50-minute presentation and a 10-minute Q-and-A session at the end of
the course. The webinar will be co-presented by Toby Odenheim, MBA, director,
clinical technology services at SynteractHCR and Cathi Sciacca, executive
director, clinical operations at Intercept Pharmaceuticals, Inc.

The webinar is tailored to managers and executives who are involved with
clinical data management and clinical system selection. The session will
demonstrate how selecting the right EDC can help ensure project success and
return on investment. The speakers will discuss how to evaluate vendors and
systems, how to identify functional and user requirements, and how to complete
a detailed assessment of the final chosen vendors.

The second webinar will be held in December. The topic will focus on how
proactive planning in study start-up drives efficiencies in drug development.
The presentation will encompass a broad overview, providing the perspectives
of sponsor, industry and CRO. More information on this session will be
released online. A third webinar will be announced at a later date.

SynteractHCR recently introduced its ICD+ platform to leverage the company's
deep clinical development expertise, appropriate technology, and optimized
execution to drive solution-oriented efficiencies and consistent standards on
a global scale. The webinar series speaks to elements of this comprehensive
methodology and identifies ways to take time and cost out of the drug
development process.

About SynteractHCR (
SynteractHCR is a full-service contract research organization with a
successful two-decade track record supporting biotechnology, medical device
and pharmaceutical companies in all phases of clinical development. With its
"Shared Work – Shared Vision" philosophy SynteractHCR provides customized
Phase I through IV services collaboratively and cost effectively ensuring
on-time delivery of quality data so clients get to decision points faster.
Operating in 16 countries, SynteractHCR delivers trials internationally,
offering expertise across multiple therapeutic areas including notable depth
in oncology, CNS, infectious disease, endocrinology, cardiovascular and
respiratory, among other indications.

Antonia Genov


Press spacebar to pause and continue. Press esc to stop.